These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: AIM ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...

Early data from the DURIPANC study shows promising safety and survival benefits of rintatolimod and durvalumab for metastatic ...

AstraZeneca has received a positive recommendation from NICE for the use of Imfinzi (durvalumab) with Imjudo (tremelimumab) ...

AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease ...

Soriot said the industry should help shape pricing reforms before they are imposed by regulators, and backed applying changes ...

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...